Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?

R Cohen, M Ashman, MK Taha, E Varon… - Infectious diseases …, 2021 - Elsevier
Since the beginning of the COVID-19 pandemic, reduced incidence of many viral and
bacterial infections has been reported in children: bronchiolitis, varicella, measles, pertussis …

Coping strategies for pertussis resurgence

X Nian, H Liu, M Cai, K Duan, X Yang - Vaccines, 2023 - mdpi.com
Pertussis (whooping cough) is a respiratory disease caused primarily by Bordetella
pertussis, a Gram-negative bacteria. Pertussis is a relatively contagious infectious disease in …

[HTML][HTML] Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018

V Bouchez, S Guillot, A Landier, N Armatys… - …, 2021 - eurosurveillance.org
Background Bordetella pertussis is the main agent of whooping cough. Vaccination with
acellular pertussis vaccines has been largely implemented in high-income countries. These …

Bordetella Type III Secretion Injectosome and Effector Proteins

J Kamanova - Frontiers in cellular and infection microbiology, 2020 - frontiersin.org
Pertussis, also known as whooping cough, is a resurging acute respiratory disease of
humans primarily caused by the Gram-negative coccobacilli Bordetella pertussis, and less …

[HTML][HTML] Pertussis in Mexico from 2000 to 2019: A real-world study of incidence, vaccination coverage, and vaccine effectiveness

G Sánchez-González, G Luna-Casas, C Mascareñas… - Vaccine, 2023 - Elsevier
Background The national immunization program in Mexico includes a 3-dose primary series
of pertussis vaccine and a toddler booster dose. In Mexico, whole-cell pertussis vaccines …

Precision vaccine development: cues from natural immunity

S Barman, D Soni, B Brook, E Nanishi… - Frontiers in …, 2022 - frontiersin.org
Traditional vaccine development against infectious diseases has been guided by the
overarching aim to generate efficacious vaccines normally indicated by an antibody and/or …

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice

J Holubová, O Staněk, L Brázdilová, J Mašín, L Bumba… - Vaccines, 2020 - mdpi.com
Bordetella pertussis whole-cell vaccines (wP) caused a spectacular drop of global pertussis
incidence, but since the replacement of wP with acellular pertussis vaccines (aP), pertussis …

Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe

D Macina, KE Evans - Infectious Diseases and Therapy, 2021 - Springer
Pertussis (whooping cough) epidemics persist globally despite high vaccine coverage
among infants and young children. The resurgence of pertussis in high-income countries is …

Novel approaches to reactivate pertussis immunity

G Blanchard-Rohner - Expert Review of Vaccines, 2022 - Taylor & Francis
Introduction Whole cell and acellular pertussis vaccines have been very effective in
decreasing the deaths of neonates and infants from Bordetella pertussis. Despite high …

[HTML][HTML] A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy

R da Silva Antunes, F Soldevila, M Pomaznoy… - JCI insight, 2021 - ncbi.nlm.nih.gov
The increased incidence of whooping cough worldwide suggests that current vaccination
against Bordetella pertussis infection has limitations in quality and duration of protection …